SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001493152-20-014963
Filing Date
2020-08-07
Accepted
2020-08-07 14:51:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 formsc-13g.htm SC 13G 177320
  Complete submission text file 0001493152-20-014963.txt   178949
Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-81034 | Film No.: 201084916
SIC: 2834 Pharmaceutical Preparations

Mailing Address 222 BROADWAY FL 19 NEW YORK NY 10038
Business Address 222 BROADWAY FL 19 NEW YORK NY 10038 646-793-9056
Ayrton Capital LLC (Filed by) CIK: 0001698148 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G